Page last updated: 2024-08-17

nad and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

nad has been researched along with Precursor B-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baloglu, E; Chen, Y; Chien, W; Ding, LW; Gery, S; Jiang, YY; Koeffler, HP; Lill, M; Lin, DC; Madan, V; Mayakonda, A; Müschen, M; Park, E; Senapedis, W; Sudo, M; Sun, QY; Takao, S; Xu, L	1

Other Studies

1 other study(ies) available for nad and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Article	Year
Targeting the vulnerability to NAD Leukemia, 2018, Volume: 32, Issue:3 Topics: Acrylamides; Aminopyridines; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytokines; Disease Models, Animal; Female; Humans; Male; Mice; NAD; Nicotinamide Phosphoribosyltransferase; p21-Activated Kinases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction; Xenograft Model Antitumor Assays	2018

Article

Year

Targeting the vulnerability to NAD

Leukemia, 2018, Volume: 32, Issue:3

Topics: Acrylamides; Aminopyridines; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytokines; Disease Models, Animal; Female; Humans; Male; Mice; NAD; Nicotinamide Phosphoribosyltransferase; p21-Activated Kinases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction; Xenograft Model Antitumor Assays

2018